BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32101261)

  • 1. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
    Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
    JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.
    Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.
    Barbieri JS; Chiesa Fuxench ZC; Shin DB; Takeshita J
    Qual Life Res; 2021 Jun; 30(6):1705-1713. PubMed ID: 33538979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.
    Rencz F; Gulácsi L; Péntek M; Szegedi A; Remenyik É; Bata-Csörgő Z; Bali G; Hidvégi B; Tamási B; Poór AK; Hajdu K; Holló P; Kinyó Á; Sárdy M; Brodszky V
    Br J Dermatol; 2020 May; 182(5):1167-1175. PubMed ID: 31419310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).
    Rencz F; Mitev AZ; Szabó Á; Beretzky Z; Poór AK; Holló P; Wikonkál N; Sárdy M; Kárpáti S; Szegedi A; Remenyik É; Brodszky V
    Qual Life Res; 2021 Aug; 30(8):2375-2386. PubMed ID: 33683650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
    Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
    Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
    Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
    J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
    Langenbruch A; Radtke MA; Gutknecht M; Augustin M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
    Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
    Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients.
    Zou Q; Luo Y; Hao D; Li M; Jihui C
    J Health Popul Nutr; 2024 Jun; 43(1):92. PubMed ID: 38909238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding happiness to complement the Dermatology Quality of Life Index in psoriasis and atopic dermatitis healthcare: a cross-sectional study.
    Schuster B; Ziehfreund S; Schielein MC; Tizek L; Biedermann T; Peifer C; Zink A
    Eur J Dermatol; 2022 Apr; 32(2):220-226. PubMed ID: 35866912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis.
    Schmitt J; Küster D
    Arch Dermatol Res; 2015 Jul; 307(5):451-3. PubMed ID: 25940274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
    van Geel MJ; Maatkamp M; Oostveen AM; de Jong EM; Finlay AY; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2016 Jan; 174(1):152-7. PubMed ID: 26361284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study.
    Cozzani E; Linder D; Burlando M; Gallo F; Sampogna F; Bruzzone M; Tacchino C; Drago F; Parodi A
    Eur J Dermatol; 2018 Jun; 28(3):332-337. PubMed ID: 29789272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis.
    Safikhani S; Sundaram M; Bao Y; Mulani P; Revicki DA
    J Dermatolog Treat; 2013 Feb; 24(1):50-9. PubMed ID: 22007701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.
    Khawaja AR; Bokhari SM; Tariq R; Atif S; Muhammad H; Faisal Q; Jafferany M
    Prim Care Companion CNS Disord; 2015; 17(3):. PubMed ID: 26644955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
    Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis.
    Mazzotti E; Picardi A; Sampogna F; Sera F; Pasquini P; Abeni D;
    Br J Dermatol; 2003 Aug; 149(2):318-22. PubMed ID: 12932238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.
    Barbieri JS; Gelfand JM
    Br J Dermatol; 2019 Nov; 181(5):1088-1090. PubMed ID: 31102266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.